Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,662.00
(
0.21%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 12
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: DewDiligence post# 177295

Friday, 04/25/2014 7:29:09 PM

Friday, April 25, 2014 7:29:09 PM

Post# of 257267
This is the price one pays for second-hand info.

Due, thank you for clarification.

Gonzalez said that ABBV’s 3-DAA HCV regimen was very well positioned for the marketplace, particularly with respect to cirrhotic and treatment-experienced patients



As I stated many times, Gild's cirrhotic pts data are not statistically meaningful.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today